Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Clin Cancer Res. 2016 May 25;22(18):4585–4593. doi: 10.1158/1078-0432.CCR-15-3101

Figure 3.

Figure 3

Computed tomography (CT) image of a patient with EGFR-mutant non-small cell lung cancer demonstrating the metastatic burden of disease along with representative images of PD-L1 immunohistochemical staining of corresponding autopsy samples. Diffuse PD-L1 expression (≥50% of tumor cells expressing PD-L1) was identified in 8 distinct metastatic sites, but not in normal lung tissue.